全膝关节置换术后患者报告结局的最小临床重要差异取决于中枢敏化
本研究纳入422例单侧全膝关节置换术并完成2年随访的膝骨关节炎患者,使用中枢敏化量表(CSI)评估中枢敏化(CS),分别在有和无CS患者中采用锚定法和分布法计算WOMAC评分的MCID。结果显示有CS患者WOMAC总分MCID(变化差异法23.4分,ROC法29.5分)大于无CS患者(14.7分和26.5分),且有CS患者MCID达成率显著更低。
要点
- 有中枢敏化的TKA患者WOMAC总分MCID为23.4分(变化差异法)或29.5分(ROC法)。
- 无中枢敏化的TKA患者WOMAC总分MCID为14.7分(变化差异法)或26.5分(ROC法)。
- 有中枢敏化患者WOMAC疼痛、功能和总分MCID达成率均显著低于无中枢敏化患者(均p<0.05)。
核心结论
- 全膝关节置换术后有中枢敏化的患者WOMAC评分MCID大于无中枢敏化患者。
- 将有和无中枢敏化患者各自的MCID应用于对应组别时,有中枢敏化患者的MCID达成率更低。
研究设计与样本
- 本研究为预后研究,证据等级为Level III。
- 共纳入422例因膝骨关节炎行单侧全膝关节置换术并完成2年随访的患者。
- 使用中枢敏化量表(CSI)测量中枢敏化,使用WOMAC评分评估术前和术后患者报告结局。
- 分别在有和无中枢敏化患者中采用锚定法和分布法计算MCID。
- 变化差异法将MCID定义为最小改善组与无变化组之间术前到术后变化值的差异,并采用ROC曲线分析计算MCID。
主要发现
- 变化差异法计算的有中枢敏化患者WOMAC总分MCID为23.4分,无中枢敏化患者为14.7分。
- ROC法计算的有中枢敏化患者WOMAC总分MCID为29.5分,无中枢敏化患者为26.5分。
- 通过变化差异法和ROC法,无中枢敏化患者WOMAC疼痛、功能和总分MCID达成率均显著高于有中枢敏化患者(均p<0.05)。
关键数值与推荐
- 有中枢敏化患者WOMAC总分MCID:变化差异法23.4分,ROC法29.5分。
- 无中枢敏化患者WOMAC总分MCID:变化差异法14.7分,ROC法26.5分。
- 无中枢敏化患者WOMAC疼痛、功能和总分MCID达成率均显著高于有中枢敏化患者(均p<0.05)。
临床怎么用
- 全膝关节置换术后评估WOMAC评分改善时,应参考患者有无中枢敏化所对应的MCID阈值。
- 有中枢敏化的患者可能需要更大的WOMAC评分改善才能达到最小临床重要差异。
- 计算MCID达成率时应使用患者所属组别(有或无中枢敏化)的相应MCID。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To our knowledge, it is still unknown if central sensitization (CS) influences the magnitude of the minimal clinically important difference (MCID) for patient-reported outcome measures after total knee arthroplasty (TKA). The purpose of this study was to determine the influence of CS on the MCID for the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score in patients who underwent TKA for knee osteoarthritis. METHODS: A total of 422 patients who underwent unilateral TKA and completed a 2-year follow-up were enrolled in this study. CS was measured using the Central Sensitization Inventory (CSI). The WOMAC score was used to evaluate preoperative and postoperative patient-reported outcomes. The measurement of the MCID was performed separately for patients with and without CS using both the anchor-based method and the distribution method. The change difference method defined the MCID as the difference in preoperative-to-postoperative change between the minimal-improvement group and the no-change group. In addition, the MCID was calculated using receiver operating characteristic (ROC) curve analysis. The percentage of MCID achievement in each group was also compared. RESULTS: According to the change difference method, the MCID for the WOMAC total score was 23.4 points for patients with CS and 14.7 points for patients without CS. The MCID using the ROC cutoff value for the WOMAC total score was 29.5 points for the patients with CS and 26.5 points for the patients without CS. MCID achievement rates in WOMAC pain, function, and total scores were all found to be significantly higher in the patients without CS through the change difference method and the ROC method (all p < 0.05). CONCLUSIONS: The MCID for the WOMAC score of patients with CS after TKA was greater than that for patients without CS. Furthermore, by applying the calculated MCID to the group to which the patients belonged (with or without CS), we determined that patients with CS showed a lower MCID achievement rate than patients without CS. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Kim MS, Koh IJ, Choi KY, et al. Minimal Clinically Important Differences for Patient-Reported Outcomes After TKA Depend on Central Sensitization. J Bone Joint Surg Am. 2021. PMID: 34014863. doi:10.2106/JBJS.20.02138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。